Trial Profile
Long-term Safety and Clinical Outcome after Postpartum Withdrawal of Telbivudine Therapy for The Prevention of Perinatal Transmission of Hepatitis B Virus Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 02 Dec 2015 New trial record